Baxter International Inc/ US0718131099 /
2024-06-26 10:10:00 PM | Chg. -0.06 | Volume | Bid10:16:03 PM | Ask10:16:03 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
33.90USD | -0.18% | 3.27 mill. Turnover: 92.54 mill. |
33.62Bid Size: 200 | 34.19Ask Size: 200 | 17.27 bill.USD | 3.42% | 6.46 |
GlobeNewswire
10:05 PM
Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
GlobeNewswire
06-20
ProvisionAi COO Terri Bennett Robbins Named One of 20 Women Reshaping the Future of Logistics and th...
GlobeNewswire
06-20
E-fuels offer long-term solution to key energy transition transport sectors, but journey needs to st...
GlobeNewswire
06-14
CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payme...
GlobeNewswire
06-12
2024 RealTrends + Tom Ferry The Thousand List Recognizes 44 eXp Realty Agents and Teams
GlobeNewswire
06-12
2024 Report: LGBTQ+ Advertising Influential Over Brand Perceptions & Purchase Decisions
GlobeNewswire
06-04
Wood Mackenzie appoints Xizhou Zhou as new head of Power and Renewables Business
GlobeNewswire
05-16
US November election results could decelerate energy transition, with $1 trillion in energy investme...
GlobeNewswire
05-15
Investigation Alert Baxter International, Eagle Pharmaceuticals, BioXcel Therapeutics, and ImmunityB...